Cartesian Growth Corporat... (RENE)
Cartesian Growth II Statistics
Share Statistics
Cartesian Growth II has 13M shares outstanding. The number of shares has increased by -39.87% in one year.
Shares Outstanding | 13M |
Shares Change (YoY) | -39.87% |
Shares Change (QoQ) | -39.87% |
Owned by Institutions (%) | 57.3% |
Shares Floating | 7.25M |
Failed to Deliver (FTD) Shares | 100K |
FTD / Avg. Volume | 879.58% |
Short Selling Information
The latest short interest is 1.13K, so 0.01% of the outstanding shares have been sold short.
Short Interest | 1.13K |
Short % of Shares Out | 0.01% |
Short % of Float | 0.02% |
Short Ratio (days to cover) | 0.01 |
Valuation Ratios
The PE ratio is 26.5 and the forward PE ratio is null. Cartesian Growth II's PEG ratio is 2.45.
PE Ratio | 26.5 |
Forward PE | n/a |
PS Ratio | 0 |
Forward PS | 0.1 |
PB Ratio | 1.95 |
P/FCF Ratio | -328.59 |
PEG Ratio | 2.45 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cartesian Growth Corporation II.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of 0.03.
Current Ratio | 0.22 |
Quick Ratio | 0.22 |
Debt / Equity | 0.03 |
Total Debt / Capitalization | 2.49 |
Cash Flow / Debt | -0.23 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.07% and return on capital (ROIC) is -1.27%.
Return on Equity (ROE) | 0.07% |
Return on Assets (ROA) | 0.07% |
Return on Capital (ROIC) | -1.27% |
Revenue Per Employee | $0 |
Profits Per Employee | $5,720,519.5 |
Employee Count | 2 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 6.48% in the last 52 weeks. The beta is -0.01, so Cartesian Growth II's price volatility has been lower than the market average.
Beta | -0.01 |
52-Week Price Change | 6.48% |
50-Day Moving Average | 11.76 |
200-Day Moving Average | 11.54 |
Relative Strength Index (RSI) | 72.15 |
Average Volume (20 Days) | 11.37K |
Income Statement
Revenue | n/a |
Gross Profit | -2.03M |
Operating Income | -2.03M |
Net Income | 11.44M |
EBITDA | 11.44M |
EBIT | n/a |
Earnings Per Share (EPS) | 0.41 |
Balance Sheet
The company has 50.93K in cash and 3.98M in debt, giving a net cash position of -3.93M.
Cash & Cash Equivalents | 50.93K |
Total Debt | 3.98M |
Net Cash | -3.93M |
Retained Earnings | -18.54M |
Total Assets | 182.78M |
Working Capital | -2.69M |
Cash Flow
In the last 12 months, operating cash flow was -922.74K and capital expenditures -5, giving a free cash flow of -922.74K.
Operating Cash Flow | -922.74K |
Capital Expenditures | -5 |
Free Cash Flow | -922.74K |
FCF Per Share | -0.03 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RENE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 3.47% |
FCF Yield | -0.6% |
Analyst Forecast
Currently there are no analyst rating for RENE.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 4.53 |
Piotroski F-Score | 3 |